You are here

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Free

Authors

  1. Correspondence to Professor Ingrid E Lundberg, Medicine, Division of Rheumatology, Karolinska Institutet, Karolinska Univeristy Hospital, Stockholm SE-171 76, Sweden; ingrid.lundberg{at}ki.se
View Full Text

Citation

Rönnelid J, Espinosa-Ortega F, Lundberg IE
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Annals of the Rheumatic Diseases 2021;80:e116.

Publication history

  • Received October 2, 2019
  • Accepted October 2, 2019
  • First published October 15, 2019.
Online issue publication 
July 06, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.